Opko Health OPK Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Diagnostics | $60.64M-24.1% | $62.92M-19.9% | $78.68M+13.8% | $76.27M+3.0% | $79.87M+15.6% | |
| Pharmaceutical | $148.44M+6.6% | $143.02M+2.2% | $147.89M+2.5% | $140.54M-21.4% | $139.2M-34.2% | |
| Revenue by Product | ||||||
| Rayaldee | $59.08M-12.1% | $59.39M-14.3% | $62.37M-9.7% | $63.36M-8.5% | $67.25M-1.7% | |
| Transfer Of Intellectual Property And Other | $81.4M+0.6% | $79.7M+3.0% | $89.11M+81.7% | $83.58M+98.7% | $80.92M-35.1% | |
| Revenue by Geography | ||||||
| CL | $62.71M-3.1% | $62.38M-4.1% | $60.88M-6.5% | $63.09M-3.7% | $64.69M-4.6% | |
| ES | $28.33M+11.5% | $26.72M+8.5% | $26.31M+5.6% | $26.27M+14.3% | $25.41M+10.2% | |
| IE | $55.6M+24.5% | $51.4M+6.2% | $47.12M-7.2% | $46.55M-2.9% | $44.65M-66.9% | |
| IL | $450K-73.3% | $523K-70.5% | $1.33M+15.7% | $1.38M-66.3% | $1.69M-68.2% | |
| MX | $26.23M+14.0% | $25.52M+6.9% | $24.51M+14.6% | $23.4M+8.1% | $23.01M+7.2% | |
| Other Countries | $4.43M+27.2% | $4.27M+36.8% | $4.04M+45.7% | $3.7M+43.4% | $3.49M+51.5% | |
| US | $403.36M-23.4% | $436.06M-20.2% | $477.89M-12.4% | $499.63M-9.4% | $526.47M-3.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Opko Health break its business down?
- Opko Health (OPK) reports gross profit by business across 2 parts — Diagnostics and Pharmaceutical. Each is extracted from the segment footnotes and tracked over time.
- Where does Opko Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Opko Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
